WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 46'9401 Infant (under 12 months) mortality rate: 22
GDP / capita (US$): 38'2301 Child (under 5 years) mortality rate: 32

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 5'408  5'389  5'368  5'344  5'318  5'176  4'987  4'779 
Births 61  61  60  60  60  57  64  65 
Surviving infants 61  60  60  60  59  57  63  64 
Pop. less than 5 years 306  304  300  297  295  294  311  320 
Pop. less than 15 years 890  888  886  890  895  940  963  971 
Female 15-49 years 1'160  1'165  1'170  1'172  1'173  1'218  1'258  1'219 

Number of reported case

(Click for retrospective incidence data for Finland)
Diphtheria
Japanese encephalitis
Measles 27  2'147 
Mumps
Pertussis 555  336  267  511  707  187 
Polio*
Rubella
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Finland)
Vaccine year result method % card seen                                                
BCG          99  97  99  91 
DTP1          99  99 
DTP3          99  99  99  99  99  90 
HepB_BD         
HepB3         
Hib3          99  99  99  98 
JapEnc         
MCV          97  97  99  97  96  97 
MCV2         
PCV1         
PCV3         
Pol3          99  99  99  97  95  90 
Rota1         
Rota_last         
Rubella1          97  97  99  97 
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Finland)
BCG 99  91  90 
DTP1 99  99  99  99  99  99  96  97 
DTP3 99  99  99  99  99  99  90  92 
HepB3
Hib3 99  99  99  98  98  96 
MCV 97  97  98  98  97  96  97 
PCV3
Pol3 99  99  99  99  97  96  90  90 
Rota_last

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90%
From 80 to 89%
From 50 to 79%
Less than 50%
Proportion of districts
not reporting DTP3 coverage
100
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG > 7 years; Yes TB in the family, parents originate from a country with high incidens, moving to such country
DTaPHibIPV 3, 5, 12 months; Yes
DTaPIPV 4 years; Yes
HepA Yes i.v drug users
HepAHepB Yes i.v. drug users
HepB Yes family members of carriers and iv. drug users, protitutes and other risk groups
IPV Yes travellers
Influenza 6-35 months; Yes Y65 and older, pregnant mothers, health workers, individual with chronic diseases
MMR 14-18 months; 6 years; Yes
MenACWY Yes military service, outbreaks
Pneumo_conj 3, 5, 12 months; Yes Medical risk group children < Y5
Pneumo_ps 2-4 years; Yes medical risk group children
Rotavirus 2, 3, 5 months; Yes
TBE >3 years; No Åland island
Td Yes dT booster
Tdap 14-15 years; Yes

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR No  No  No  No  No    No 
What years does the MYP cover? number             NA 
Nº of districts with microplans that include activities to raise immunization coverage number      

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR Yes  Yes  Yes         

System performance

Total number of districts in country number       NA  NA  NA  NA 
Nº districts with DTP3 coverage >=80% number          
% of districts with DTP3 coverage >=80% From 0 to 100%              
Nº districts with measles (MCV1) coverage >=95% number          
% of districts with MCV1 coverage >=95% From 0 to 100%              

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND No  No  No         

Finance

Percentage of routine vaccines funded by Government From 0 to 100% 100  100  100  100  100  100 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.